◆英語タイトル：Voyager Therapeutics Inc (VYGR) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Voyager Therapeutics Inc (Voyager) is a gene therapy company that discovers, develops and commercializes therapies to treat severe neurological diseases. It is evaluating VY-AADC program for the treatment of advanced Parkinson’s disease; VY-SOD102 against monogenic amyotrophic lateral sclerosis (ALS); VY-HTT01 to treat Huntington’s disease; and VY-FXN01 program targeting Friedreich’s ataxia. The company is also investigating therapies against tauopathies including Alzheimer’s disease (AD), frontotemporal lobar degeneration (FTD), Pick’s disease, progressive supranuclear palsy (PSP) and corticobasal degeneration. It works in collaboration with Neurocrine Biosciences Inc, Genzyme Corp, University of California San Francisco and University of Massachusetts Medical School (UMMS) to develop its programs. Voyager is headquartered in Cambridge, Massachusetts, the US.
Voyager Therapeutics Inc Key Recent Developments
Feb 25,2021: Voyager Therapeutics announces fourth quarter and full year 2020 financial results and corporate updates
Feb 18,2021: Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference
Jan 15,2021: Voyager Therapeutics : Resignation of Wendy Dixon from Board of Directors
Nov 09,2020: Voyager Therapeutics announces third quarter 2020 financial results and corporate updates
Sep 15,2020: Voyager Therapeutics appoints Nancy Vitale to its board of directors
This comprehensive SWOT profile of Voyager Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Voyager Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Voyager Therapeutics Inc – Key Information
Voyager Therapeutics Inc – Overview
Voyager Therapeutics Inc – Key Employees
Voyager Therapeutics Inc – Key Employee Biographies
Voyager Therapeutics Inc – Key Operational Heads
Voyager Therapeutics Inc – Major Products and Services
Voyager Therapeutics Inc – History
Voyager Therapeutics Inc – Company Statement
Voyager Therapeutics Inc – Locations And Subsidiaries
Voyager Therapeutics Inc
Other Locations & Subsidiaries
Section 2 – Company Analysis
Voyager Therapeutics Inc – Business Description
Voyager Therapeutics Inc – Corporate Strategy
Voyager Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Voyager Therapeutics Inc – Strengths
Voyager Therapeutics Inc – Weaknesses
Voyager Therapeutics Inc – Opportunities
Voyager Therapeutics Inc – Threats
Voyager Therapeutics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Voyager Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Voyager Therapeutics Inc, Key Information
Voyager Therapeutics Inc, Key Ratios
Voyager Therapeutics Inc, Share Data
Voyager Therapeutics Inc, Major Products and Services
Voyager Therapeutics Inc, History
Voyager Therapeutics Inc, Key Employees
Voyager Therapeutics Inc, Key Employee Biographies
Voyager Therapeutics Inc, Key Operational Heads
Voyager Therapeutics Inc, Other Locations
Voyager Therapeutics Inc, Subsidiaries
Voyager Therapeutics Inc, Key Competitors
Voyager Therapeutics Inc, SWOT Analysis
Voyager Therapeutics Inc, Ratios based on current share price
Voyager Therapeutics Inc, Annual Ratios
Voyager Therapeutics Inc, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[Voyager Therapeutics Inc (VYGR)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら